The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation

por Ditz, Diana, Rabanus, Robert, Schulz, Christian, Wolff, Daniel, Holler, Barbara, Holler, Ernst, Hildebrandt, Gerhard Carl
Publicado 2016

IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

por Kattner, Anna-Sophia, Holler, Ernst, Holler, Barbara, Klobuch, Sebastian, Weber, Daniela, Martinovic, Danilo, Edinger, Matthias, Herr, Wolfgang, Wolff, Daniel
Publicado 2020

Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis

por Fante, Matthias A., Holler, Barbara, Weber, Daniela, Angstwurm, Klemens, Bergler, Tobias, Holler, Ernst, Edinger, Matthias, Herr, Wolfgang, Wertheimer, Tobias, Wolff, Daniel
Publicado 2020

Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis

por Wertheimer, Tobias, Dohse, Marius, Afram, Gabriel, Weber, Daniela, Heidenreich, Martin, Holler, Barbara, Kattner, Anna-Sophia, Neubauer, Andreas, Mielke, Stephan, Ljungman, Per, Holler, Ernst, Herr, Wolfgang, Edinger, Matthias, Martínez, Antonio Pérez, Fante, Matthias, Wolff, Daniel
Publicado 2021